Abstract
INTRODUCTION
Vascular diseases cover an extended selection of pathologies comprising cardiovascular, thoracoa bdominal, peripheral vascular and cerebrovascular disease [1] . Smoking is considered one of the main risk factors for the development of atherosclerosis and, in particular, oxidative stress and inflammation that constitute the physiological connection between smoking and vascular diseases. Polycyclic aromatic hydrocarbons (PAH) represent the main carcinogenic compound found in cigarettes, produced during the incomplete combustion of organic matter. Many ar ticles demonstrate the double activity of PAH, both carcinogenic (lung and other tissues) and inflammatory, provoking endothelial dysfunction and several studies demonstrate that oxidants directly impair endothelial function, increasing nitric oxide scavenging by oxygen free radicals [26] . In the literature it is well known that cardiovascular diseases are often diagnosed on the basis of imaging findings, such as suspected atherosclerotic plaques of the chest in computed tomography (CT), also incidentally [79] . A similar approach should be used to identify extravascular findings, when the CT examination is required to explore vascular diseases. In particular, since cigarette smoking is the main risk factor for both vascular and neoplastic lung diseases, radiologists should examine the chest in evaluation of vascular patients with many risk factors suggesting possible synchronous pathologies. It has been reported that CTs requested for the exclusion of pulmonary embolism give a high yield of chest abnormalities, such as mediastinal adenopathy, paratracheal adenopathy, atelectasis, emphysema and pulmonary nodules or masses [10, 11] .
Although not the target of the investigation, lung abnormalities, especially lung cancer, could become the main finding with prognostic relevance in terms of lifelong survivor risk in vascular patients. Furthermore, even if many articles over the last decade have reported the problem of unsuspected thoracic findings in CTs performed for suspected pulmonary embolism or thoracic aortic pathology, the possibility of finding chest pathology, and in particular lung cancer in smoker patients suffering from vascular disease, has been underestimated [12, 13] . Moreover, several articles have reported a high cumulative radiation dose in patients treated with endovascular aneurysm repair (EVAR), both during the interventional procedure and CT follow up, suggesting a possible role of radiation exposure in developing cancer in these patients [1416] . On the contrary, there have been no articles to date about the discovery of lung cancer during EVAR planning or surveillance in smokers suggesting that smoking rather than the exposure of patients to radiation is the main risk factor for lung cancer. Considering the previous statements, the purpose of this study is to assess the prevalence of lung cancer in patients with a smoking attitude, who underwent computed tomography angio graphy (CTA) for planning or monitoring EVAR in our department.
MATERIALS AND METHODS

Patient characteristics
Institutional review board approval was obtained for this retrospective study, as well as informed consent from all subjects. We reviewed the report results of 250 CTs of patients referred to our department for EVAR planning or followup between June 2014 and May 2016, searching for lung abnormalities in the patients who underwent high resolution computed tomography (HRCT) of the lung before contrast agent administration. Patients were identified throughout a digital radiological database (Picture Archive and Communication System, PACS) which registers all radiological studies performed by the Department of Radiology. The mean age of patients at the time of CT was 71 years, in a range from 50 to 94, and 38 (21%) were female. Sixtynine (26.6%) patients were excluded for the following reasons: 30 (43.5%) because of the absence of synchronous chest HRCT, 21 (30.4%) because of lack of proven histological findings of lung cancer or HRCT follow-up examinations, and 18 (26.1%) because of nonsmoking attitude. The CTA and HRCT were performed simultaneously in all selected cases to avoid interpretation bias. Seventyfour (40.8%) CTs were performed for EVAR planning and 107 for EVAR surveillance (67 at 1 mo and 40 at 12 mo after EVAR). All the selected patients had a documented history of smoking [number of packyears (py)] [1719] .
Imaging technique
All the CTs were performed with a 64detector row CT scanner (Discovery HD 750, General Electric Healthcare, and Milwaukee, United States). HRCTs were acquired at end of inspiration using volumetric technique in the caudocranial direction from the basis to the apex of the lung; patients were in supine position. The following technical parameters were used: Effective slice thickness 3.75 mm, collimation 40 mm, beam pitch 0.969, reconstruction interval 1 mm, tube voltage 140 kVp and reference mAs 250/400. Automatic tube current modulation was used to minimise radiation exposure. Chest CTs were acquired using a standard algorithm, then data were reconstructed by using a high spatialfrequency algorithm (bone plus), with 1.25 mm slice thickness. Abdominal CT angiography (CTA) was performed with a spiral technique in the caudocranial direction (from the pelvic brim to the lung bases) with the patients supine. Patients were instructed to hold their breath during helical imaging to avoid motion artefacts. After a scoutview scan, intravenous injection of 1.5 mL/kg nonionic contrast material (Iomeprol 400 mg iodine/mL; Iomeron 400, Bracco Diagnostics, Milan, Italy) followed by 40 mL saline solution was administered with an 18gauge needle in the antecubital vein, using a dual-barrel injector (4 mL/s flow rate, CT Motion, Ulrich Medical, Ulm, Germany). Arterial phase images were obtained 4 seconds after bolus detection in the suprarenal aorta. The following technical parameters were used: Effective slice thickness 1.25 mm, colli mation 40 mm, beam pitch 0.969, reconstruction interval 0.8 mm, tube voltage 140 kVp and reference mAs 250/700. A standard reconstruction algorithm was used. In 24 out of 181 patients (13.2%), the contrast CT was extended to the thorax using the same technical parameters. Automatic tube current modulation was also used to minimise radiation exposure in the post contrast examination [16] .
Image analysis
All images were analysed independently and blindly by two readers with 15 and 8 years' experience in chest imaging respectively. HRCT scans were analysed on a reconstruction and image interpretation console (Advantage Workstation 4.4, GE Healthcare, Milwaukee, Wis, United States), adjusting the image level, window and enlargement values each time, and routinely using a 2D multiplanar reconstruction technique (coronal, sagittal and oblique planes). Pulmonary HRCT findings included: Pleural effusion, atelectasis/pneumonia, pericardial effusion, cardiomegaly, coronary artery calcifications, bone findings, hiatal hernia, emphysema, mediastinal or hilar adenopathy, pulmonary micronodule (< 4 mm), pulmonary nodule (> 4 mm and < 30 mm) and pulmonary mass (> 30 mm). The readers recorded any incidental finding, with particular attention to pulmonary nodules or masses and differences were resolved by consensus. All nodules were characterised by number, size (measured in their greatest diameter) and CT characteristic appearance (solid, groundglass or partially solid, edge characteristics, speculated or smooth, presence or absence of pleuraltag, bronchus sign, calcifications, intralesional fat or intralesional air) and reviewed with the smoking history of the patient. According to Fleischner Society guidelines, all suspected nodules were addressed to CT biopsy or surgical intervention, whereas nodules with a CT low risk appearance for lung cancer were addressed to CT followup [20] (Table 14) . All previous medical reports, clinical notes, discharges summaries and medical histories of patients were examined to potentially define every mass or nodule as a new incidental finding.
Statistical analysis
The lung findings detected by the readers were co llected, and the results expressed as mean ± SD. A descriptive statistical analysis was performed; the quantitative variables were expressed as means and range whereas the qualitative values as percentages.
The statistical review of the study was performed by a biomedical statistician. The analysis was performed using Stata version 8.0 (Stata Corp, College Station, Texas).
RESULTS
A total of 181 HRCTs were reviewed. The incidental lung findings reported on chest CT are shown in Table  5 . There were a total of 102 (56%) nodules in 92 out of 181 (50.8%) HRCTs, with a mean of 1.79 nodules per patient and an average diameter of 9.2 mm, ranging from 4 to 56 mm. All the CT nodules characteristics are reported in Table 6 . After radiologists' review, 82 (76.4%) of the nodules met criteria for CT followup and were submitted to a second HRCT examination (performed between 612 mo), to exclude the possibility of malignant evolution. 
DISCUSSION
EVAR currently represents a safe and effective treat ment for abdominal aortic aneurysms exclusion with an increase in the choice of this treatment over traditional open repair, especially in elderly patients [21, 22] . In particular, EVAR is also becoming the method of choice for aneurysmal sac exclusion in vascular patients Table 3 Recommendations for follow-up and management of single subsolid nodule [20] Nodule size (mm) Ground-glass Part solid 
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Nodule size (mm)
< 6
CT at 3-6 mo. If stable, consider CT at 2 and 4 yr ≥ 6
CT at 3-6 mo. Subsequent management based on the most suspicious nodule(s) Table 4 Recommendations for follow-up and management of multiple subsolid nodules [20] CT: Computed tomography. with difficult vascular anatomies due to its favourable outcomes, customised approach and easy technical execution [2325] . Despite these advantages some articles debate the risk of longterm lifelong EVAR CT follow up, with a remarkable amount of radiation exposure carrying the risk of developing cancers; moreover they report the need of dose optimisations using new targeted CT protocols, considering that the absorbed dose by the patient differs on the basis different scanners, patient body size and age [2628] . However to our knowledge there are no articles discussing the prevalence of lung cancer, prior to EVAR treatment, in patients with a smoking attitude. Furthermore, lung cancer represents the most important cause of death in the world, and the majority of patients suffering from lung cancer present mild or no symptoms, with nodular lesions being the most common presentation of peripheral lung adenocarcinoma [12] . Moreover, a large number of patients with vascular disease have a smoking history and, in particular, smoking is one of the major risk factors for developing vascular diseases. At the same time, smoking also represents the main risk factor for lung cancer due to the activation of the same inflammatory pathway with continuous endothelial damage. In our study we assess the prevalence of lung nodules through HRCT in a cohort of smoker patients who underwent abdominal CTA for planning or followup EVAR; considering the mean advanced age of patients (71 years), stochastic radiation damage deriving from the extra dose of HRCT (respectively mean CTDI 12.6 mGy (range 9.415.2) for HRCT vs 22.3 mGy (19.824.3) for abdominal CTA) can be considered negligible, comparing to the benefit of early tumor detection; in fact 9 out of 102 nodules (8.8%) in 9 out of 181 (4.9%) patients were finally diagnosed as lung cancer with consequent surgery (6 patients), chemotherapeutic treatment (1 patient) or both (2 patients), with a free survivor rate of 100% at one years. All the other patients were correctly addressed to the appropriate treatment or followup. In this context, performing HRCT of the lung to optimise morphological evaluation of lung nodules and/or adding advanced imaging procedure such as CT perfusion or CT volu metric assessment of lung nodules during CTA for the evaluation of vascular aneurysm, offers radiologists the possibility of performing a differential diagnosis between benign or malignant nodules, choosing the correct ma nagement for each patient [2933] . Moreover, CTA can be performed in the emergency setting to exclude or confirm the presence of aneurysmal sac or EVAR complications or to investigate an abdominal pain after a doubtful ultrasound examination; incidental findings can also occur in that setting [3437] . In fact several articles in the literature have reported the possibility of discovering coexistent neoplasms such as gastrointestinal and gall bladder cancers during CT examination of vascular patients [3840] . Our study had some limitations. First of all, it is a retrospective study with some possible bias in patient selection, although the database used to find the patients was complete in medical records. Secondly, not all the patients underwent a prior chest radiography that could exclude patients with negative reports from the study. Additionally, a prospective study is mandatory to test the real impact of incidental findings in smoker patients who underwent EVAR planning or followup, in order to support the introduction of HRCT of the lung in the CT protocol for smoker patients.
In conclusion, this study actually demonstrates the possibility of early diagnosis of lung cancers during CTA EVAR planning or followup, overcoming the concept of dose radiation induced neoplasms, especially in patients over the age of 65.
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